Indeed ESRP1, by regulating the alternative splicing of its target, CD44, also promotes lung metastasis of 4T1 breast cancer cells as well as brain-metastatic progression of melanoma, with elevated ESRP1 expression negatively correlating with patient survival [9,10]. This evidence concerns the gene ESRP1 and breast carcinoma.